Darolutamide (Nubeqa, BAY1841788) Clinical Trials
3 recruitingDrug
Phase 41Phase 31
Showing 1–3 of 3 trials
Recruiting
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Non-metastatic Castration-resistant Prostate Cancer
Bayer600 enrolled1 locationNCT06334120
Recruiting
Phase 4
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Non-metastatic Castration-resistant Prostate Cancer
Bayer50 enrolled25 locationsNCT05348876
Recruiting
Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Cancer
Bayer402 enrolled383 locationsNCT04464226